PT1307262E - Processo para encontrar compostos que sejam adequados para o tratamento e/ou profilaxia da obesidade - Google Patents

Processo para encontrar compostos que sejam adequados para o tratamento e/ou profilaxia da obesidade

Info

Publication number: PT1307262E
Authority: PT; Portugal
Prior art keywords: profilaxia; obesity; treatment; finding compounds; finding
Prior art date: 2000-07-20

Application number

PT01955345T

Other languages

English (en)

Inventor

Jochen Antel

Holger Sann

Johannes Hebebrand

Ulf Preuschoff

Samuel David

Michael Weske

Original Assignee

Solvay Pharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-20

Filing date

2001-07-12

Publication date

2004-12-31

2001-07-12 Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh

2004-12-31 Publication of PT1307262E publication Critical patent/PT1307262E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Wood Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Immunology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

PT01955345T 2000-07-20 2001-07-12 Processo para encontrar compostos que sejam adequados para o tratamento e/ou profilaxia da obesidade PT1307262E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10035227A DE10035227A1 (de)	2000-07-20	2000-07-20	Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind

Publications (1)

Publication Number	Publication Date
PT1307262E true PT1307262E (pt)	2004-12-31

Family

ID=7649538

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT01955345T PT1307262E (pt)	2000-07-20	2001-07-12	Processo para encontrar compostos que sejam adequados para o tratamento e/ou profilaxia da obesidade

Country Status (27)

Country	Link
EP (1)	EP1307262B1 (pt)
JP (1)	JP2004504053A (pt)
KR (1)	KR100818827B1 (pt)
CN (1)	CN1443085B (pt)
AR (1)	AR028730A1 (pt)
AT (1)	ATE278441T1 (pt)
AU (2)	AU7753401A (pt)
BR (1)	BR0112547A (pt)
CA (1)	CA2416647A1 (pt)
CZ (1)	CZ2003156A3 (pt)
DE (2)	DE10035227A1 (pt)
DZ (1)	DZ3393A1 (pt)
ES (1)	ES2230346T3 (pt)
HK (1)	HK1057499A1 (pt)
HU (1)	HUP0302309A3 (pt)
IL (2)	IL153971A0 (pt)
MX (1)	MXPA02012907A (pt)
NO (1)	NO20030233L (pt)
NZ (1)	NZ523960A (pt)
PL (1)	PL201165B1 (pt)
PT (1)	PT1307262E (pt)
RU (1)	RU2268721C2 (pt)
SK (1)	SK287607B6 (pt)
TR (1)	TR200402670T4 (pt)
TW (1)	TWI274157B (pt)
UA (1)	UA74588C2 (pt)
WO (1)	WO2002007821A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0510137A (pt)	2004-05-19	2007-10-02	Solvay Pharm Gmbh	medicamentos contendo n-sulfamoil-n'-arilpiperazinas para a profilaxia ou tratamento da obesidade e condições relacionadas
MY147767A (en)	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CN101754947A (zh)	2005-05-20	2010-06-23	詹森药业有限公司	磺酰胺衍生物的制备方法
TW200804393A (en)	2005-11-14	2008-01-16	Solvay Pharm Gmbh	Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use
US8492431B2 (en)	2005-12-19	2013-07-23	Janssen Pharmaceutica, N.V.	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8716231B2 (en)	2005-12-19	2014-05-06	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en)	2005-12-19	2014-04-08	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en)	2005-12-19	2013-07-30	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en)	2005-12-19	2015-01-20	Janssen Pharmaceutica Nv	Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EP2026790A2 (en)	2006-05-19	2009-02-25	Janssen Pharmaceutica, N.V.	Co-therapy for the treatment of epilepsy and related disorders
WO2008089521A1 (en)	2007-01-25	2008-07-31	Verva Pharmaceuticals Ltd	Insulin sensitisers and methods of treatment
PE20110060A1 (es)	2008-06-23	2011-01-31	Janssen Pharmaceutica Nv	Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
US8815939B2 (en)	2008-07-22	2014-08-26	Janssen Pharmaceutica Nv	Substituted sulfamide derivatives
CA2874513A1 (en) *	2012-05-24	2013-11-28	Verva Pharmaceuticals Ltd	A method of improving liver function
CN106770611B (zh) *	2016-12-22	2019-01-29	广西师范大学	一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) *	2021-09-21	2022-05-04	Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН)	Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4552897A (en) *	1983-02-01	1985-11-12	American Cyanamid Company	Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) *	1987-09-04	2001-09-11	Beecham Group P.L.C.	Compounds
US5126324A (en) *	1990-06-07	1992-06-30	Genentech, Inc.	Method of enhancing growth in patients using combination therapy
DK0669832T3 (da) *	1992-10-29	1997-03-17	Genentech Inc	Fremgangsmåde til behandling eller forebyggelse af fedme
AU693478B2 (en) *	1994-11-10	1998-07-02	Metabolic Pharmaceuticals Limited	Treatment of obesity
CN1106193C (zh) *	1996-06-28	2003-04-23	奥索·麦克尼尔药品公司	抗惊厥剂氨基磺酸酯衍生物用于治疗肥胖的用途
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor

2000
- 2000-07-20 DE DE10035227A patent/DE10035227A1/de not_active Withdrawn
2001
- 2001-06-15 AR ARP010102883A patent/AR028730A1/es unknown
- 2001-07-12 SK SK61-2003A patent/SK287607B6/sk not_active IP Right Cessation
- 2001-07-12 PT PT01955345T patent/PT1307262E/pt unknown
- 2001-07-12 RU RU2003104803/14A patent/RU2268721C2/ru not_active IP Right Cessation
- 2001-07-12 AU AU7753401A patent/AU7753401A/xx active Pending
- 2001-07-12 PL PL363518A patent/PL201165B1/pl not_active IP Right Cessation
- 2001-07-12 MX MXPA02012907A patent/MXPA02012907A/es active IP Right Grant
- 2001-07-12 ES ES01955345T patent/ES2230346T3/es not_active Expired - Lifetime
- 2001-07-12 NZ NZ52396001A patent/NZ523960A/xx not_active IP Right Cessation
- 2001-07-12 AT AT01955345T patent/ATE278441T1/de active
- 2001-07-12 DE DE50104023T patent/DE50104023D1/de not_active Expired - Lifetime
- 2001-07-12 AU AU2001277534A patent/AU2001277534B9/en not_active Ceased
- 2001-07-12 CA CA002416647A patent/CA2416647A1/en not_active Abandoned
- 2001-07-12 WO PCT/EP2001/008051 patent/WO2002007821A1/de active IP Right Grant
- 2001-07-12 KR KR1020037000620A patent/KR100818827B1/ko not_active IP Right Cessation
- 2001-07-12 TR TR2004/02670T patent/TR200402670T4/xx unknown
- 2001-07-12 BR BR0112547-8A patent/BR0112547A/pt not_active Application Discontinuation
- 2001-07-12 IL IL15397101A patent/IL153971A0/xx unknown
- 2001-07-12 EP EP01955345A patent/EP1307262B1/de not_active Expired - Lifetime
- 2001-07-12 CN CN018129730A patent/CN1443085B/zh not_active Expired - Fee Related
- 2001-07-12 JP JP2002513551A patent/JP2004504053A/ja active Pending
- 2001-07-12 CZ CZ2003156A patent/CZ2003156A3/cs unknown
- 2001-07-12 HU HU0302309A patent/HUP0302309A3/hu unknown
- 2001-07-12 DZ DZ013393A patent/DZ3393A1/xx active
- 2001-07-16 TW TW090117382A patent/TWI274157B/zh not_active IP Right Cessation
- 2001-12-07 UA UA2003021453A patent/UA74588C2/uk unknown
2003
- 2003-01-15 IL IL153971A patent/IL153971A/en not_active IP Right Cessation
- 2003-01-17 NO NO20030233A patent/NO20030233L/no unknown
2004
- 2004-01-15 HK HK04100307.4A patent/HK1057499A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUP0302309A3 (en)	2005-06-28
CA2416647A1 (en)	2003-01-20
UA74588C2 (en)	2006-01-16
RU2268721C2 (ru)	2006-01-27
AU2001277534B2 (en)	2005-09-29
PL363518A1 (en)	2004-11-29
AU7753401A (en)	2002-02-05
NO20030233D0 (no)	2003-01-17
JP2004504053A (ja)	2004-02-12
NO20030233L (no)	2003-03-19
ES2230346T3 (es)	2005-05-01
NZ523960A (en)	2004-12-24
SK612003A3 (en)	2003-06-03
HK1057499A1 (en)	2004-04-08
DE10035227A1 (de)	2002-01-31
CZ2003156A3 (cs)	2003-06-18
CN1443085B (zh)	2010-04-28
AU2001277534B9 (en)	2006-02-23
MXPA02012907A (es)	2003-09-22
TWI274157B (en)	2007-02-21
HUP0302309A2 (hu)	2003-11-28
IL153971A0 (en)	2003-07-31
KR100818827B1 (ko)	2008-04-01
IL153971A (en)	2009-07-20
BR0112547A (pt)	2003-07-01
EP1307262B1 (de)	2004-10-06
DZ3393A1 (fr)	2002-01-31
CN1443085A (zh)	2003-09-17
EP1307262A1 (de)	2003-05-07
TR200402670T4 (tr)	2004-11-22
DE50104023D1 (de)	2004-11-11
WO2002007821A1 (de)	2002-01-31
PL201165B1 (pl)	2009-03-31
KR20030022284A (ko)	2003-03-15
SK287607B6 (sk)	2011-03-04
ATE278441T1 (de)	2004-10-15
AR028730A1 (es)	2003-05-21

Publication	Publication Date	Title
PT1307262E (pt)	2004-12-31	Processo para encontrar compostos que sejam adequados para o tratamento e/ou profilaxia da obesidade
NO20035611D0 (no)	2003-12-16	Sammensetning og fremgangsmåte for kontroll ved behandling av hydrokarbon
AR028454A1 (es)	2003-05-07	Metodos para el ensamblaje enzimatico de polinucleotidos e identificacion de polinucleotidos que tienen caracteristicas deseadas
PT1313489E (pt)	2005-05-31	Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
FI20011421L (fi)	2002-12-30	Menetelmä ja laite toiminnon toteuttamiseksi
PT1144395E (pt)	2005-08-31	Derivados de 2-aminobenzoxazinona para o tratamento da obesidade
EP1274444A4 (en)	2006-06-14	COMPOUNDS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS OR DISORDERS CAUSED BY THE ABUSE OF PSYCHOACTIVE SUBSTANCES
PT1143977E (pt)	2005-08-31	Derivados de 2-oxibenzoxazinona para o tratamento da obesidade
BR0115842B1 (pt)	2011-11-16	dispositivo e processo para aplicação regulada de adesivos e/ou selantes.
PT1265615E (pt)	2005-05-31	Nova combinacao de anti-histaminicos nao sedativos com substancias que influenciam o efeito dos leucotrienos para o tratamento de rinite/conjuntivite
BR9508886A (pt)	1997-12-30	Compostos e métodos para o tratamento de câncer
PT1147083E (pt)	2004-09-30	Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
BR0202519B1 (pt)	2012-09-18	métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira.
DE60115872D1 (de)	2006-01-19	Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom
NO20025307D0 (no)	2002-11-05	Anvendelse av IL-18 inhibitorer til behandling og/eller forebygging av aterosklerose
PT1206436E (pt)	2004-12-31	Retinoides para o tratamento de enfisema
BR0011210B1 (pt)	2013-05-28	mÉtodo e aparelho para esterilizaÇço com ozânio.
PT1345944E (pt)	2005-08-31	Processo para o isolamento e purificacao de epotilonas
FI20011370A0 (fi)	2001-06-27	Biotunnistusmenetelmä ja sitä hyödyntävä laite
BR0104595B1 (pt)	2010-10-19	processo e aparelho para colar transversalmente faixas ou tiras de folheado.
FI20011298L (fi)	2003-02-10	Puunkäsittelyliuos ja menetelmä puun säilyvyyden parantamiseksi
PT1274700E (pt)	2005-02-28	Di-hidrobenzopiranos di-hidrobenzotiopiranos e tetra-hidroquinolinas para o tratamento de afeccoes mediadas por cox-2
PT1021200E (pt)	2002-07-31	Metodos e composicoes para o tratamento da artrite reumatoide
BR0214799B1 (pt)	2011-11-16	instalação flutuante para tratamento de hidrocarbonetos.
PT1051172E (pt)	2005-03-31	Metodo para tratamento da dpco